当前位置: X-MOL 学术Interdiscip. Cardiovasc. Thorac. Surg. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Prognostic factor analysis for patient outcome of PD-L1 expression in thoracic oesophageal squamous cell carcinoma
Interdisciplinary CardioVascular and Thoracic Surgery ( IF 1.978 ) Pub Date : 2021-07-29 , DOI: 10.1093/icvts/ivab149
Bo Wu 1 , Jianhua Gao 1 , Muyuan Ma 1 , Yuanyuan Wu 1 , Xiaofeng Ye 1
Affiliation  

Abstract
OBJECTIVES
The purpose of this study was to determine the expression of PD-L1 in oesophageal squamous cell carcinoma (OSCC) and the prognostic factors.
METHODS
PD-L1 expression was investigated by immunohistochemical staining of resected specimens from 50 OSCC patients who were randomly selected from 104 patients with complete follow-up data. The relationships among PD-L1 expression, clinicopathological factors and prognosis were assessed by statistical analysis.
RESULTS
The expression of PD-L1 was positive in 27 (54%, positive cells’ proportion > 25%) and negative in 23 (46%, positive cells proportion ≤25%) of 50 cases, and PD-L1 expression was negative in all pericarcinomatous tissues (P > 0.05). The 5-year survival rate of patients with PD-L1-positive expression was 22.2% (6 of 27), which was less than that of patients with PD-L1-negative expression (47.8%; 11 of 23) (P < 0.05). The results showed significant differences in the depth of tumour invasion, lymph node status, postoperative pathological stage and PD-L1 expression (P < 0.05). Multivariable analysis showed that PD-L1 expression was an independent prognostic factor for survival.
CONCLUSIONS
The depth of tumour invasion, lymph node status, postoperative pathological stage and PD-L1 expression are important factors affecting the prognosis of patients with thoracic OSCC; in particular, high PD-L1 expression was a significant independent poor prognostic factor in thoracic OSCC patients.


中文翻译:

胸段食管鳞状细胞癌中PD-L1表达的预后因素分析

摘要
目标
本研究的目的是确定 PD-L1 在食管鳞状细胞癌 (OSCC) 中的表达及其预后因素。
方法
通过对 50 名 OSCC 患者的切除标本进行免疫组织化学染色研究 PD-L1 表达,这些患者从 104 名具有完整随访数据的患者中随机选择。通过统计分析评估PD-L1表达、临床病理因素和预后之间的关系。
结果
50例PD-L1表达阳性27例(54%,阳性细胞比例>25%),阴性23例(46%,阳性细胞比例≤25%),PD-L1表达均为阴性癌周组织(P  > 0.05)。PD-L1 阳性表达患者的 5 年生存率为 22.2%(27 人中有 6 人),低于 PD-L1 表达阴性患者(47.8%;23 人中有 11 人)(P  < 0.05 ) )。结果显示,肿瘤浸润深度、淋巴结状态、术后病理分期和PD-L1表达差异有统计学意义(P  < 0.05)。多变量分析表明,PD-L1 表达是生存的独立预后因素。
结论
肿瘤浸润深度、淋巴结状态、术后病理分期和PD-L1表达是影响胸部OSCC患者预后的重要因素;特别是,高 PD-L1 表达是胸部 OSCC 患者的重要独立不良预后因素。
更新日期:2021-10-07
down
wechat
bug